These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37204618)

  • 1. Pathological complete response with nivolumab for recurrence of liver metastasis after gastrectomy of gastric cancer.
    Jun C; Yamauchi S; Yube Y; Egawa H; Yoshimoto Y; Kubota A; Tsuda K; Kaji S; Orita H; Oka S; Mine S; Fukunaga T
    Surg Case Rep; 2023 May; 9(1):86. PubMed ID: 37204618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conversion surgery for gastric remnant cancer with liver metastasis after nivolumab combination chemotherapy achieving pathological complete response: a case report and literature review.
    Katsumata K; Morimoto Y; Aoyama J; Yamada T; Katsuki Y; Nishiyama R; Egawa T
    Surg Case Rep; 2024 May; 10(1):107. PubMed ID: 38691201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report.
    Matsumoto R; Arigami T; Matsushita D; Okubo K; Tanaka T; Yanagita S; Sasaki K; Noda M; Kita Y; Mori S; Kurahara H; Ohtsuka T
    World J Surg Oncol; 2020 Jul; 18(1):179. PubMed ID: 32693806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful R0 resection after chemotherapy, including nivolumab, for gastric cancer with liver metastases: three case reports.
    Kawai J; Yasufuku I; Fukada M; Asai R; Sato Y; Tajima YJ; Saigo C; Kiyama S; Makiyama A; Tanaka Y; Okumura N; Murase K; Miyazaki T; Matsuhashi N
    Surg Case Rep; 2024 Jun; 10(1):138. PubMed ID: 38837046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of liver metastases arising from early gastric cancer achieved clinical complete response by nivolumab.
    Namikawa T; Ishida N; Tsuda S; Fujisawa K; Munekage E; Iwabu J; Munekage M; Uemura S; Tsujii S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
    Surg Case Rep; 2018 Jul; 4(1):71. PubMed ID: 29978335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case report.
    Arigami T; Matsushita D; Okubo K; Tanaka T; Sasaki K; Noda M; Kita Y; Mori S; Tsuruda Y; Kurahara H; Ohtsuka T
    Surg Case Rep; 2020 Oct; 6(1):271. PubMed ID: 33074364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy.
    Watanabe H; Fujikawa H; Komori K; Kano K; Takahashi K; Yamada T; Inokuchi Y; Machida N; Yokose T; Rino Y; Masuda M; Ogata T; Oshima T
    Case Rep Gastroenterol; 2021; 15(2):562-567. PubMed ID: 34616257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Brain Metastasis Arising from Gastric Cancer during Long-Term Treatment Using Nivolumab].
    Namikawa T; Marui A; Yokota K; Kawanishi Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K
    Gan To Kagaku Ryoho; 2022 Dec; 49(13):1544-1546. PubMed ID: 36733129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical complete response after nivolumab administered as a third-line treatment for unresectable advanced gastric cancer with peritoneal dissemination: A case report.
    Komo T; Suzuki T; Tazawa H; Sada H; Morimoto H; Shimada N; Hadano N; Onoe T; Sudo T; Shimizu Y; Tashiro H
    Int J Surg Case Rep; 2021 Jul; 84():106161. PubMed ID: 34237686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case of Long-Term Survival with Recurrent Liver Metastases from Gastric Cancer Treated with Nivolumab.
    Horiuchi A; Akehi S; Fujiwara Y; Kawaharada S; Anai T
    Case Rep Oncol; 2024; 17(1):438-446. PubMed ID: 38455714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report.
    Hidaka Y; Arigami T; Osako Y; Desaki R; Hamanoue M; Takao S; Kirishima M; Ohtsuka T
    World J Surg Oncol; 2022 Jun; 20(1):193. PubMed ID: 35689267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response.
    Baettig F; Vlajnic T; Vetter M; Glatz K; Hench J; Frank S; Bihl M; Lopez R; Dobbie M; Heinzelmann-Schwarz V; Montavon C
    J Immunother Cancer; 2019 Oct; 7(1):281. PubMed ID: 31672171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A Case of Initially Unresectable Advanced Gastric Cancer Radically Resected by Conversion Surgery after Nivolumab Immunotherapy].
    Koizumi N; Kashiwagi S; Ogino S; Kamada Y; Fujiki H; Sakakura C
    Gan To Kagaku Ryoho; 2020 Nov; 47(11):1624-1626. PubMed ID: 33268741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nivolumab exerts therapeutic effects against metastatic lesions from early gastric adenocarcinoma with a small proportion of neuroendocrine carcinoma after gastrectomy: a case report.
    Sawayama H; Komohara Y; Hirao H; Sakata K; Takata N; Yoshinaka I; Harada K; Baba H
    Clin J Gastroenterol; 2020 Oct; 13(5):759-765. PubMed ID: 32592148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confirmed complete response to nivolumab for advanced gastric cancer with peritoneal dissemination: a case report.
    Takami T; Yasuda K; Uozumi N; Musiake Y; Shintani H; Kataoka N; Yamaguchi T; Makimoto S
    J Med Case Rep; 2021 Dec; 15(1):604. PubMed ID: 34930435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful management of multiple liver metastasis from gastric cancer with second conversion surgery: A case report.
    Sato S; Tanabe K; Ota H; Saeki Y; Ohdan H
    Int J Surg Case Rep; 2023 Jun; 107():108340. PubMed ID: 37216732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and efficacy of laparoscopic surgery in locally advanced gastric cancer patients with neoadjuvant chemotherapy combined with immunotherapy].
    Lv JB; Yin YP; Zhang P; Cai M; Chen JH; Li W; Li G; Wang Z; Wang GB; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Jan; 26(1):84-92. PubMed ID: 36650004
    [No Abstract]   [Full Text] [Related]  

  • 18. [Long-Term Response of Nivolumab for Recurrent Lymph Nodes after Surgery for Gastric Cancer-A Case Report].
    Katsuyama S; Takeno A; Masuzawa T; Sugimura K; Kihara Y; Haruna K; Shinke G; Ikeshima R; Kawai K; Hiraki M; Katsura Y; Ohmura Y; Hata T; Takeda Y; Murata K
    Gan To Kagaku Ryoho; 2021 Dec; 48(13):1868-1870. PubMed ID: 35045431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated adrenocorticotropic hormone deficiency induced by nivolumab treatment for advanced gastric cancer.
    Namikawa T; Shimizu S; Yokota K; Tanioka N; Fukudome I; Munekage M; Uemura S; Maeda H; Kitagawa H; Hanazaki K
    Clin J Gastroenterol; 2021 Aug; 14(4):988-993. PubMed ID: 33715100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report: Complete Remission of a Patient With Metastatic Gastric Cancer Treated With Nivolumab Combined With Chemotherapy After Palliative Surgery.
    Dai P; Rao X; Zhang X; Qiu E; Wu G; Lin Y; Li S; Li Z; Cai Z; Han S
    Front Immunol; 2022; 13():908558. PubMed ID: 35844567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.